Abrdn Life Sciences Investors (HQL)
NYSE: HQL · Real-Time Price · USD
16.95
+0.09 (0.53%)
Jun 12, 2026, 4:00 PM EDT - Market closed
HQL Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | - | 0.08 | 0 | 0 | 0 | 0 |
Cash & Short-Term Investments | 0.85 | 0.08 | 0 | 0 | 0 | 0 |
Cash Growth | 85160100.00% | 7553700.00% | -99.79% | 7.19% | -55.05% | - |
Accounts Receivable | 1.27 | 1.14 | 0.23 | 5.04 | 0.62 | 0.15 |
Other Receivables | 0.01 | 0.01 | 0.01 | - | - | - |
Receivables | 1.28 | 1.15 | 0.24 | 5.04 | 0.62 | 0.15 |
Prepaid Expenses | 0.05 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 |
Other Current Assets | - | - | - | 15.24 | 11.09 | 8.47 |
Total Current Assets | 2.18 | 1.26 | 0.28 | 20.31 | 11.74 | 8.64 |
Long-Term Investments | 547.79 | 465.24 | 446.4 | 382.06 | 391.52 | 481.17 |
Other Long-Term Assets | 13.25 | 48.88 | 13.9 | 0.23 | 11.47 | 44.37 |
Total Assets | 563.23 | 515.38 | 460.58 | 402.6 | 414.73 | 534.19 |
Accounts Payable | 0.02 | 0.72 | 0 | - | 5.1 | - |
Accrued Expenses | 0.74 | 0.57 | 0.84 | 0.67 | 0.63 | 0.7 |
Short-Term Debt | - | - | - | - | 11.09 | 10.04 |
Other Current Liabilities | 0.07 | 0.43 | 0.05 | - | - | - |
Total Current Liabilities | 0.83 | 1.73 | 0.89 | 0.67 | 16.82 | 10.75 |
Other Long-Term Liabilities | 1.57 | - | - | - | - | - |
Total Liabilities | 2.4 | 1.73 | 0.89 | 0.67 | 16.82 | 10.75 |
Common Stock | 0.3 | 0.3 | 0.28 | 0.27 | 0.26 | 0.25 |
Additional Paid-In Capital | 449.15 | 435.76 | 415.29 | 403.15 | 388.1 | 372.49 |
Retained Earnings | 111.37 | 77.6 | 44.13 | -1.48 | 9.55 | 150.7 |
Shareholders' Equity | 560.83 | 513.66 | 459.69 | 401.93 | 397.9 | 523.44 |
Total Liabilities & Equity | 563.23 | 515.38 | 460.58 | 402.6 | 414.73 | 534.19 |
Total Debt | - | - | - | - | 11.09 | 10.04 |
Net Cash (Debt) | 0.85 | 0.08 | 0 | 0 | -11.09 | -10.04 |
Net Cash Growth | 85160100.00% | 7553700.00% | -99.79% | - | - | - |
Net Cash Per Share | 0.03 | 0.00 | - | 0.00 | -0.43 | -0.41 |
Filing Date Shares Outstanding | 30.41 | 29.6 | 28.06 | 26.79 | 25.68 | 24.67 |
Total Common Shares Outstanding | 30.41 | 29.6 | 28.06 | 26.79 | 25.68 | 24.67 |
Working Capital | 1.36 | -0.46 | -0.61 | 19.65 | -5.08 | -2.1 |
Book Value Per Share | 18.44 | 17.35 | 16.38 | 15.00 | 15.49 | 21.22 |
Tangible Book Value | 560.83 | 513.66 | 459.69 | 401.93 | 397.9 | 523.44 |
Tangible Book Value Per Share | 18.44 | 17.35 | 16.38 | 15.00 | 15.49 | 21.22 |